Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 3, 2025

Primary Completion Date

December 29, 2028

Study Completion Date

September 30, 2029

Conditions
Inflammatory Bowel Disease
Interventions
BEHAVIORAL

MBC-IBD Intervention

Measurement Based Care for Inflammatory Bowel Disease - Intervention group. Veteran participants who are randomized to 12-months of MBC-IBD will be enrolled for 12 months. They will each complete surveys at baseline, 6-months, and 12-months post-randomization. After baseline completion, participants will be asked to complete weekly surveys. These assessments require completion of self-report questionnaires (PROs) which will be completed by phone or electronically using VA REDCap. MBC in IBD will not replace but rather provide care continuity between clinic visits. Patients allocated to MBC in IBD will receive automated reminders to complete weekly questionnaires. Further, patients will receive quarterly reports of their PRO data trends.

OTHER

Enhanced Treatment as Usual (E-TAU)

E-TAU will receive standard of care, including monitoring and treatment as directed at the discretion of their gastroenterologist. Participants will also receive educational videos and fact sheets on various IBD-specific topics.

Trial Locations (4)

30033-4004

Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur

48105-2303

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

97207-2964

VA Portland Health Care System, Portland, OR, Portland

77030-4211

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT07210580 - Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter